BioSpace News Archive

Press Releases

Spyre Therapeutics to Participate in Upcoming November 2024 Investor Conferences

October 31, 2024
·
1 min read
Press Releases

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

October 31, 2024
·
4 min read
Press Releases

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

October 31, 2024
·
2 min read
Press Releases

Bausch Health Announces Third Quarter 2024 Results

October 31, 2024
·
44 min read
Press Releases

Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab

October 31, 2024
·
5 min read
Press Releases

Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura

October 31, 2024
·
5 min read
Press Releases

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

October 31, 2024
·
6 min read
Press Releases

Kelun-Biotech’s TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC

October 31, 2024
·
4 min read
Press Releases

Ultimovacs ASA: Invitation to third quarter 2024 results webcast presentation

October 31, 2024
·
1 min read
Press Releases

Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

October 31, 2024
·
8 min read